We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

In Levaquin Patent Battle, Daiichi Scores Again

Law360 (March 20, 2006, 12:00 AM EST) -- In its second big win in a high-stakes patent battle over the anti-infective drug Levaquin, Japanese drug maker Daiichi Pharmaceutical Co. has been granted summary judgment on its motion for no...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.